Veselibas centru apvieniba AS

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis3 trials
• Crohn's disease2 trials
• Diabetic eye disease1 trial
• Heart failure1 trial
• Myasthenia gravis1 trial
• Osteoporosis1 trial
• Type 2 diabetes1 trial

Phase

• Phase 38 trials
• Phase 21 trial

Status

• Active, not recruiting6 trials
• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• AbbVie4 trials
• Novo Nordisk A/S2 trials
• Curateq Biologics Private Limited1 trial
• Dianthus Therapeutics1 trial
• Eli Lilly & Co.1 trial

Running trials

• Recruiting

  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  NCT07647510· Phase 3· Dianthus Therapeutics· Source

• Recruiting

  A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

  2025-524404-29-00· Phase 2· Eli Lilly & Co.· Source

• Active, not recruiting

  HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation.

  NCT05636176· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  NCT03811561· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

  NCT03398135· Phase 3· AbbVie· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

  NCT03105102· Phase 3· AbbVie· Source

• Active, not recruiting

  A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

  NCT03345823· Phase 3· AbbVie· Source

• Active, not recruiting

  A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

  NCT03006068· Phase 3· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myasthenia gravis1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis

  2023-503790-37-00· Phase 3· Curateq Biologics Private Limited· Source